Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Molecular Medicine Reports
Join Editorial Board Propose a Special Issue
Print ISSN: 1791-2997 Online ISSN: 1791-3004
Journal Cover
2014-April Volume 9 Issue 4

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
2014-April Volume 9 Issue 4

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article

Effect of transforming growth factor-β1 on acute lung injury caused by paraquat

  • Authors:
    • Baotian Kan
    • Xiangdong Jian
    • Qian Zhou
    • Jieru Wang
    • Guangcai Yu
    • Jing Sun
    • Yikai Gao
  • View Affiliations / Copyright

    Affiliations: Department of Poisoning and Occupational Disease, Qilu Hospital of Shandong University, Jinan, Shandong 250012, P.R. China
  • Pages: 1232-1236
    |
    Published online on: February 7, 2014
       https://doi.org/10.3892/mmr.2014.1938
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

In China, and other Asian countries, numerous patients have succumbed to pulmonary fibrosis induced by paquarat poisoning, but the early pathogenesis remains unclear. In this study the effect of cytokine transforming growth factor (TGF)-β1 was observed in early acute paraquat poisoning and examined the mechanism by which paraquat caused early acute lung injury. It was discovered that the rat serum TGF-β1 levels in the paraquat groups were significant higher than that in the control group (P<0.05) and the rat pulmonary TGF-β1 mRNA expression levels were also higher than that in the control group (P<0.05). Histological examination indicated that the rat lung tissue was broad and congested, and had been infiltrated by inflammatory cells. Masson's trichrome staining for collagen showed that the lung tissue appeared fibrotic following paraquat poisoning. Ultramicrostructure observation found that macrophages, red blood cells, lymphocytes and granulocytes infiltrated the alveolar space and there were cytolysosomes in the macrophages. The shape of the type II alveolar epithelial cell nuclei were irregular with karyopyknosis. The heterochromatin migrated to the cell edge and lamellar body vacuolization was also observed. Type I alveolar epithelial cells shrank. In conclusion, the effect of cytokine TGF-β1 on paraquat-induced acute lung tissue injury may be important.

Introduction

Paraquat is one of the most widely used herbicides worldwide, and has been approved for use by authorities in >120 countries. It is used on numerous crop types and is important for controlling weeds on plantation estates (1–3). For these reasons, it is particularly popular in the Chinese countryside and is widely used by Chinese farmers (4). Paraquat is highly toxic for humans, and many cases of acute poisoning, particularly cases of intentional self-poisoning, have been reported over the past few decades in China. In addition, nearly all treatments for paraquat poisoning are unsuccessful (5). Agricultural chemical intoxication is the major cause of poisoning, and it remains a major cause of death of among Chinese farm workers. Ingestion of large quantities of paraquat results in rapid mortality, of which acute lung injury is the one of the major causes. However, smaller doses often result in delayed lung fibrosis that is also usually fatal. Little is known with regard to the pathogenesis of acute lung injury and the fibrosis caused by paraquat. Therefore, it is imperative to understand the underlying mechanisms. Paraquat-induced pulmonary fibrosis involves two factors, direct injury by oxygen free radicals and indirect injury by inflammatory cells and fibroblasts (6,7). Certain patients may develop pulmonary fibrosis, which may progressively improve over time (8,9). Paraquat is known to induce toxicity in cells by stimulating oxygen utilization via redox cycling and the generation of reactive oxygen intermediates (10–12). However, the exact role of paraquat in the progression of pathogenesis has not been clearly established (13–15).

Transforming growth factor-β1 (TGF-β1) contributes to the fibrosis of injured organs (16). Abnormal expression of TGF-β1 is hypothesized to be important in the pathogenesis of pulmonary fibrosis (17). In order to understand the mechanism of paraquat-induced pulmonary toxicity, an animal model of paraquat-induced lung injury was developed by intragastrically administering paraquat solution to Wistar rats. The pathological progression of lung pathology in the rat model was similar to that of patients presenting with paraquat poisoning. The aim of this study was to establish the role of TGF-β1 in acute lung injury caused by paraquat.

Materials and methods

Preparation of animal model

In total 32, 240–260 g, healthy adult male Wistar rats (SPF, Code SCXK20100004, provided by the Experimental Animal centre of Shandong University, Jinan, China) were randomly assigned to the normal control group (n=8), 30 mg/kg paraquat (20% wt/vol, imported from Syngenta AG, Basel, Switzerland) poisoning group (n=8), 60 mg/kg paraquat poisoning group (n=8) and 120 mg/kg paraquat poisoning group (n=8). Paraquat-treated rats were administered the corresponding dose of 1 ml paraquat by lavaging while the control group rats were administered 1 ml distilled water. The rats were sacrificed with anaesthetic 48 h after paraquat poisoning, and the serum and partial right lung tissues were frozen at −70°C. Other lung tissues were maintained in formaldehyde and glutaraldehyde for histopathological inspection. The stuy was approved by Experimental Animal Ethics Committee of Qilu Hospital of Shandong University (Jinan, China).

Measurement of serum TGF-β1

The rat serum TGF-β1 levels were determined by enzyme linked immunosorbent assay (ELISA) according to the manufacturer’s instructions [Shanghai SenXiong Biotech Industry Co., Ltd (Shanghai, China), imported from R&D Systems (Minneapolis, MN, USA)]. The assay method used was as follows: All reagents were prepared and 100 μl of standard or activated samples were added to the appropriate wells. The plate was covered and incubated at 37°C for 2 h. Each well was aspirated and washed, and the process was repeated three times for a total of four washes. For washing, each well was filled with wash buffer (400 μl) using a squirt bottle, multi-channel pipette, manifold dispenser or autowasher. The complete removal of liquid at each step was essential for successful analysis. After the final wash, any remaining wash buffer by was removed by aspirating or decanting. The plate was inverted and blotted with clean paper towels. Biotin-conjugated anti-rat TGF-β1 (50 μl) from the kit was added to each well, followed by incubation for 1 h at 37°C and a further aspiration/wash. Working streptavidin-horseradish peroxidase conjugate (100 μl) was added to each well, followed by incubation for 1 h at 37°C and a further aspiration/wash. Next, 100 μl working substrate solution was added to each well, followed by incubation at 37°C for 5–10 minutes in the dark. Stop solution (50 μl) was then added to each well and the absorbance was measured with a Bio-Rad Model 680 microplate reader (Bio-Rad, Hercules, CA, USA) at 492 nm within 1 h.

Analysis of rat lung tissue TGF-β1 mRNA expression

Fluorescence quantitative PCR (qPCR) was used to measure lung tissue TGF-β1 mRNA expression. Takara RNAiso reagent (Takara Bio, Inc., Shiga, Japan; code no. D312) was used initially to extract sample total RNA and DNase I (Takara Bio Inc.; code no. D2215) was used in the procedure. qPCR was performed using the Takara SYBR® ExScript™ RT-PCR kit (Takara Bio Inc.; code no. DRR053) (Table I).

Table I

Primer sequences.

Table I

Primer sequences.

Gene nameSequenceLength (mer)GC (%)Size (bp)
Rat-TGF-β1-F 5′-TGCGCCTGCAGAGATTCAAG-3′2055.0082
Rat-TGF-β1-R 5′-AGGTAACGCCAGGAATTGTTGCTA-3′2445.83
Rat-Actb-F 5′-GGAGATTACTGCCCTGGCTCCTA-3′2356.52150
Rat-Actb-R 5′-GACTCATCGTACTCCTGCTTGCTG-3′2454.17

[i] GC, gas chromatography; TGF-β1, transforming growth factor-β1; F, forward; R, reverse.

The RT reaction included 2 μl of 5X ExScript Buffer, 0.25 μl ExScript RTase, 0.25 μl RNase inhibitor (40 U/μl), 2 μl dNTP mixture (10 mM), 0.5 μl Oligo dT Primer (50 μM), 0.5 μl random 6 mers (100 μM), 1 μl RNA (50 ng) and 3.5 μl RNase Free dH2O. The total reaction volume was 10 μl and the conditions were as follows: 37°C for 15 min and 85°C for 5 sec.

The PCR reaction included 12.5 μl 2X SYBR Premix ExTaq, 0.5 μl Primer F/R (each 10 μM), 2 μl RT product and 10 μl dH2O. The total reaction volume was 25 μl and the conditions were as follows: 95°C for 10 sec, then 95°C for 5 sec and 65°C for 30 sec, for 45 cycles. The main relative instruments used are Takara PCR Thermal Cycler dice (Takara Bio Inc.; code no. TP600) and Takara PCR Thermal Cycler Dice Real-Time system (Takara Bio Inc.; code no. TP800).

Histopathological inspection of rat model

Lung tissues underwent histopathological inspection according to routine methods. Tissues from the right lung were obtained and maintained in formaldehyde or glutaraldehyde. Sections were created for histopathological inspection. We observed the sections under a light microscope (XSP-44X9; Shanghai Optical Instrument Factory, Shanghai, China), while the ultramicrostructure were observed under an electron microscope (JEM-100SX, JEOL, Tokyo, Japan).

Statistical analysis

Data are expressed as the mean ± standard deviation where indicated. Statistical differences were analyzed according to the analysis of the t-test. P<0.05 was considered to indicate a statistically significant difference. SPSS software, version 16.0 (SPSS, Inc., Chicago, IL, USA) was used to analysis the data.

Results

Changes in rats serum TGF-β1 levels caused by paraquat poisoning

Rat serum TGF-β1 levels of the paraquat groups were significantly higher than that of the control group (P<0.05, Table II and Fig. 1).

Figure 1

Changes in rat serum TGF-β1 levels following paraquat poisoning (μg/l, mean ± standard deviation). aP<0.05 compared with control group. TGF-β1, transforming growth factor-β1.

Table II

Changes in rats serum TGF-β1 levels following paraquat poisoning.

Table II

Changes in rats serum TGF-β1 levels following paraquat poisoning.

GroupnTGF-β1 (μg/l)
Control873.07±27.28
Paraquat (30 mg/kg)8707.25±195.91a
Paraquat (60 mg/kg)8975.12±165.65a
Paraquat (120 mg/kg)8 1113.12±241.75a

{ label (or @symbol) needed for fn[@id='tfn2-mmr-09-04-1232'] } Values are presented as the mean ± standard deviation. t-test,

a P<0.05, compared with control group.

{ label (or @symbol) needed for fn[@id='tfn4-mmr-09-04-1232'] } TGF-β1, transforming growth factor-β1.

Rat pulmonary TGF-β1 mRNA expression caused by paraquat poisoning

The expression of pulmonary TGF-β1 mRNA was markedly higher than that of the control group, and a significant difference was observed (P<0.05, Table III and Fig. 2).

Figure 2

Expression of rat TGF-β1 mRNA levels caused by paraquat poisoning (μg/l, mean ± standard deviation). aP<0.05 compared with control group. TGF-β1, transforming growth factor-β1.

Table III

Expression of rat TGF-β1 mRNA levels caused by paraquat poisoning (μg/l, mean ± standard deviation).

Table III

Expression of rat TGF-β1 mRNA levels caused by paraquat poisoning (μg/l, mean ± standard deviation).

GroupnTGF-β1 (μg/l)
Control81.2455±0.1849
Paraquat (30 mg/kg)81.5616±0.1990a
Paraquat (60 mg/kg)81.6003±0.1976a
Paraquat (120 mg/kg)81.8376±0.2563a

{ label (or @symbol) needed for fn[@id='tfn5-mmr-09-04-1232'] } Values are presented as the mean ± standard deviation. t-test,

a P<0.05, compared with control group.

{ label (or @symbol) needed for fn[@id='tfn7-mmr-09-04-1232'] } TGF-β1, transforming growth factor-β1.

Pathology observation

Histological examination indicated that lung tissue appeared broad and congested with numerous infiltrating inflammatory cells, and the emergence of early interstitial fibrosis. Partial lung alveoli tissues were disorganized. Vascular endothelial cells demonstrated cloudy swelling and granular degeneration (Fig. 3). Masson’s trichrome staining for collagen revealed lung tissue fibrosis following paraquat poisoning (Fig. 4).

Figure 3

Changes in rat lung tissue in paraquat groups, (hematoxylin and eosin staining; magnification, ×100). (A) Lung tissue appeared broad and congested, with numerous infiltrating inflammatory cells. The majority of the alveoli of the lung remained integrated in the 30 mg/kg group. (B) Increasing numbers of inflammatory cells infiltrated the lung tissue. Certain lung alveoli were destroyed. Fibrin effusion was also found in certain lung alveoli in the 60 mg/kg group. (C) Lung alveoli were destroyed and numerous inflammatory cells were observed. Vascular endothelial cells exhibited swelling and granular degeneration, 120 mg/kg group.

Figure 4

Changes in rat lung tissue in paraquat groups (Masson’s trichrome staining; magnification, ×100). (A) Lung tissue appears to be marginally fibrotic in the 30 mg/kg group. (B) Lung tissue appears with some fibrosis in the 60 mg/kg group. (C) Lung tissue appears to have increasing fibrosis in the 120 mg/kg group.

Ultramicrostructure observation

Ultramicrostructure observation revealed numerous macrophages, red blood cells, lymphocytes and granulocytes in the alveolar space and numerous cytolysosomes in the macrophages. The shape of the type II alveolar epithelial cell nuclei was irregular, heterochromatin migrated to the cell edge and lamellar body vacuolization was also observed. Type II alveolar epithelial cell karyolemma exhibited marked swelling and karyopyknosis. Type I alveolar epithelial cells underwent caryon pyknosis and shrank (Fig. 5).

Figure 5

Ultramicrostructure changes in rat lung tissue in the paraquat group, 120 mg/kg; magnification, ×4,000. (A) Type II alveolar epithelial cells nuclei exhibited karyolemma swelling, pyknosis, vacuolization of the lamellar body, type I alveolar epithelial cell exhibited karyopyknosis and had shrunk. (B) The shape of type II alveolar epithelial cell nucleus was irregular, the heterochromatin migrated to the cell edge and vacuolization of the lamellar body was also observed. (C) Numerous red blood cells were observed in the alveolar space.

Discussion

Recently studies have shown that cytokines have an important role in the occurrence of pulmonary fibrosis. Cytokine secretion has been implicated as a fundamental component in the process of lung fibrosis, observed in response to bleomycin (18). Although paraquat is known to induce pulmonary injury, the mechanism by which it does so is unclear (19). Paraquat accumulates in the lung through a characteristic polyamine uptake system. Several studies have been undertaken with regard to paraquat as a useful tool for the exploration of the early pathogenesis of pulmonary injury (20).

Paraquat is a well-known pneumotoxicant and provides an established model of oxidative stress. Respiratory failure is a frequent cause of mortality in cases of moderate to severe paraquat poisoning. Certain results indicate that the acclimation to oxidative stress is a highly complex process at the onset of paraquat-induced damage (1,8,21). Mainwaring et al (22) reported that a number of the transcriptional responses to paraquat were rapid, and that the predominant molecular functions and biological processes associated with these genes included membrane transport, oxidative stress, lung development, epithelial cell differentiation and TGF-β1 signaling (22). In the present study, it was demonstrated that paraquat was capable of increasing rat serum TGF-β1 levels early. TGF-β1 mRNA expression of the rat lung was also increased significantly by paraquat and followed by acute lung injury. We also found that numerous inflammatory cells infiltrated the injured rat lung alveoli. The abnormal expression of TGF-β1 is hypothesized to be important in the pathogenesis of a number of chronic inflammatory and immune lung diseases, including asthma, chronic obstructive pulmonary disease and pulmonary fibrosis (23). In the present study it was demonstrated that TGF-β1 levels increased significantly following paraquat poisoning, simultaneous to the development of lung injury developed. Thus, it was conclude that TGF-β1 may contribute to acute lung injury.

Paraquat-induced pulmonary toxicity is characterized by the initial development of pulmonary edema, the infiltration of inflammatory cells and damage to the alveolar epithelium, which may progress to severe fibrosis. However, the exact role of paraquat in the progression of pathogenesis has not been clearly established. The pathological progression of lung pathology in the rat model was similar to that found in paraquat-poisoned patients. Certain cytokines, such as TGF-β1, which potentially regulates fibrosis have yet to be identified. In the future the use of cytokines and their inhibitors may provide novel therapies for the treatment of acute lung injury and pulmonary fibrosis.

References

1 

Bismuth C, Hall AH, Baud FJ and Borron S: Pulmonary dysfunction in survivors of acute paraquat poisoning. Vet Hum Toxicol. 38:220–222. 1996.PubMed/NCBI

2 

Kurniawan AN: Product stewardship of paraquat in Indonesia. Int Arch Occup Environ Health. 68:516–518. 1996. View Article : Google Scholar : PubMed/NCBI

3 

Hart TB: Paraquat - a review of safety in agricultural and horticultural use. Hum Toxicol. 6:13–18. 1987. View Article : Google Scholar : PubMed/NCBI

4 

Kan BT, Liu HM, Jian XD, et al: Clinical studies of dynamic changes on the renal injury indicators of acute paraquat poisoning. Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi. 30:839–841. 2012.(In Chinese).

5 

Zhang Q, Wu WZ, Lu YQ, et al: Successful treatment of patients with paraquat intoxication: three case reports and review of the literature. J Zhejiang Univ Sci B. 13:413–418. 2012. View Article : Google Scholar : PubMed/NCBI

6 

Kim HR, Park BK, Oh YM, et al: Green tea extract inhibits paraquat-induced pulmonary fibrosis by suppression of oxidative stress and endothelin-I expression. Lung. 184:287–295. 2006. View Article : Google Scholar : PubMed/NCBI

7 

Mohammadi-Karakani A, Ghazi-Khansari M and Sotoudeh M: Lisinopril ameliorates paraquat-induced lung fibrosis. Clin Chim Acta. 367:170–174. 2006. View Article : Google Scholar : PubMed/NCBI

8 

Yamashita M, Yamashita M and Ando Y: A long-term follow-up of lung function in survivors of paraquat poisoning. Hum Exp Toxicol. 19:99–103. 2000. View Article : Google Scholar : PubMed/NCBI

9 

Ghaffari AR, Noshad H, Ostadi A and Hasanzadeh N: Effect of pulse therapy with glucocorticoid and cyclophosphamide in lung fibrosis due to paraquat poisoning in rats. Saudi Med J. 32:249–253. 2011.PubMed/NCBI

10 

Gray JP, Heck DE, Mishin V, et al: Paraquat increases cyanide-insensitive respiration in murine lung epithelial cells by activating an NAD(P)H: paraquat oxidoreductase: identification of the enzyme as thioredoxin reductase. J Biol Chem. 282:7939–7949. 2007. View Article : Google Scholar

11 

Takizawa M, Komori K, Tampo Y and Yonaha M: Paraquat-induced oxidative stress and dysfunction of cellular redox systems including antioxidative defense enzymes glutathione peroxidase and thioredoxin reductase. Toxicol In Vitro. 21:355–363. 2007. View Article : Google Scholar

12 

Griffith KL, Shah IM, Myers TE, et al: Evidence for ‘pre-recruitment’ as a new mechanism of transcription activation in Escherichia coli: the large excess of SoxS binding sites per cell relative to the number of SoxS molecules per cell. Biochem Biophys Res Commun. 291:979–986. 2002.

13 

Huh JW, Hong SB, Lim CM, et al: Sequential radiologic and functional pulmonary changes in patients with paraquat intoxication. Int J Occup Environ Health. 12:203–208. 2006. View Article : Google Scholar : PubMed/NCBI

14 

Tomita M, Okuyama T, Katsuyama H, et al: Mouse model of paraquat-poisoned lungs and its gene expression profile. Toxicology. 231:200–209. 2007. View Article : Google Scholar : PubMed/NCBI

15 

Ghazi-Khansari M, Mohammadi-Karakani A, Sotoudeh M, et al: Antifibrotic effect of captopril and enalapril on paraquat-induced lung fibrosis in rats. J Appl Toxicol. 27:342–349. 2007. View Article : Google Scholar : PubMed/NCBI

16 

Chen CM, Chou HC, Hsu HH and Wang LF: Transforming growth factor-β1 upregulation is independent of angiotensin in paraquat-induced lung fibrosis. Toxicology. 216:181–187. 2005.

17 

Son JY, Kim SY, Cho SH, et al: TGF-β1 T869C polymorphism may affect susceptibility to idiopathic pulmonary fibrosis and disease severity. Lung. 191:199–205. 2013.

18 

Ortiz LA, Lasky J, Hamilton RF Jr, et al: Expression of TNF and the necessity of TNF receptors in bleomycin-induced lung injury in mice. Exp Lung Res. 24:721–743. 1998. View Article : Google Scholar : PubMed/NCBI

19 

Satomi Y, Tsuchiya W, Miura D, et al: DNA microarray analysis of pulmonary fibrosis three months after exposure to paraquat in rats. J Toxicol Sci. 31:345–355. 2006. View Article : Google Scholar : PubMed/NCBI

20 

Dinis-Oliveira RJ, De Jesus Valle MJ, Bastos ML, et al: Kinetics of paraquat in the isolated rat lung: Influence of sodium depletion. Xenobiotica. 36:724–737. 2006. View Article : Google Scholar : PubMed/NCBI

21 

Tomita M, Okuyama T, Katsuyama H, et al: Gene expression in rat lungs during early response to paraquat-induced oxidative stress. Int J Mol Med. 17:37–44. 2006.PubMed/NCBI

22 

Mainwaring G, Lim FL, Antrobus K, et al: Identification of early molecular pathways affected by paraquat in rat lung. Toxicology. 225:157–172. 2006. View Article : Google Scholar : PubMed/NCBI

23 

Kopiński P, Sladek K, Szczeklik J, et al: Expression of insulin-like growth factor-I (IGF-I) in alveolar macrophages and lymphocytes obtained by bronchoalveolar lavage (BAL) in interstitial lung diseases (ILD). Assessment of IGF-I as a potential local mitogen and antiapoptotic cytokine. Folia Histochem Cytobiol. 44:249–258. 2006.

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Kan B, Jian X, Zhou Q, Wang J, Yu G, Sun J and Gao Y: Effect of transforming growth factor-β1 on acute lung injury caused by paraquat. Mol Med Rep 9: 1232-1236, 2014.
APA
Kan, B., Jian, X., Zhou, Q., Wang, J., Yu, G., Sun, J., & Gao, Y. (2014). Effect of transforming growth factor-β1 on acute lung injury caused by paraquat. Molecular Medicine Reports, 9, 1232-1236. https://doi.org/10.3892/mmr.2014.1938
MLA
Kan, B., Jian, X., Zhou, Q., Wang, J., Yu, G., Sun, J., Gao, Y."Effect of transforming growth factor-β1 on acute lung injury caused by paraquat". Molecular Medicine Reports 9.4 (2014): 1232-1236.
Chicago
Kan, B., Jian, X., Zhou, Q., Wang, J., Yu, G., Sun, J., Gao, Y."Effect of transforming growth factor-β1 on acute lung injury caused by paraquat". Molecular Medicine Reports 9, no. 4 (2014): 1232-1236. https://doi.org/10.3892/mmr.2014.1938
Copy and paste a formatted citation
x
Spandidos Publications style
Kan B, Jian X, Zhou Q, Wang J, Yu G, Sun J and Gao Y: Effect of transforming growth factor-β1 on acute lung injury caused by paraquat. Mol Med Rep 9: 1232-1236, 2014.
APA
Kan, B., Jian, X., Zhou, Q., Wang, J., Yu, G., Sun, J., & Gao, Y. (2014). Effect of transforming growth factor-β1 on acute lung injury caused by paraquat. Molecular Medicine Reports, 9, 1232-1236. https://doi.org/10.3892/mmr.2014.1938
MLA
Kan, B., Jian, X., Zhou, Q., Wang, J., Yu, G., Sun, J., Gao, Y."Effect of transforming growth factor-β1 on acute lung injury caused by paraquat". Molecular Medicine Reports 9.4 (2014): 1232-1236.
Chicago
Kan, B., Jian, X., Zhou, Q., Wang, J., Yu, G., Sun, J., Gao, Y."Effect of transforming growth factor-β1 on acute lung injury caused by paraquat". Molecular Medicine Reports 9, no. 4 (2014): 1232-1236. https://doi.org/10.3892/mmr.2014.1938
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team